Cargando…
Chloride intracellular channel protein 2 is secreted and inhibits MMP14 activity, while preventing tumor cell invasion and metastasis
The abilities to invade surrounding tissues and metastasize to distant organs are the most outstanding features that distinguish malignant from benign tumors. However, the mechanisms preventing the invasion and metastasis of benign tumor cells remain unclear. By using our own rat distant metastasis...
Autores principales: | Ozaki, Saya, Umakoshi, Akihiro, Yano, Hajime, Ohsumi, Shota, Sumida, Yutaro, Hayase, Erika, Usa, Eika, Islam, Afsana, Choudhury, Mohammed E., Nishi, Yusuke, Yamashita, Daisuke, Ohtsuka, Yoshihiro, Nishikawa, Masahiro, Inoue, Akihiro, Suehiro, Satoshi, Kuwabara, Jun, Watanabe, Hideaki, Takada, Yasutsugu, Watanabe, Yuji, Nakano, Ichiro, Kunieda, Takeharu, Tanaka, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260957/ https://www.ncbi.nlm.nih.gov/pubmed/34229297 http://dx.doi.org/10.1016/j.neo.2021.06.001 |
Ejemplares similares
-
Chloride intracellular channel protein 2 in cancer and non-cancer human tissues: relationship with tight junctions
por: Ueno, Yoshitomo, et al.
Publicado: (2019) -
BOT-04 POSSIBLE INVOLVEMENT OF CHLORIDE INTRACELLULAR CHANNEL PROTEIN 2 (CLIC2) IN THE SUPPRESSION OF INVASIVE ACTIVITY OF BRAIN TUMORS
por: Ozaki, Saya, et al.
Publicado: (2019) -
CBMS-04 SIGNIFICANT ROLE OF HYPOXIA IN THE EXPRESSION AND FUNCTION OF OSTEOPONTIN IN CD44-HIGHLY EXPRESSED GLIOMA STEM-LIKE CELLS IN TUMOR PROGRESSION OF GLIOBLASTOMA
por: Nishikawa, Masahiro, et al.
Publicado: (2019) -
ANGI-2 Identification and functions of CD44 as a predictor for bevacizumab-resistant glioblastoma to optimally treat the tumor with bevacizumab
por: Inoue, Akihiro, et al.
Publicado: (2021) -
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)